Detalhe da pesquisa
1.
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
Brain
; 146(3): 977-990, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348614
2.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Proc Natl Acad Sci U S A
; 118(1)2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33376202
3.
Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.
Ann Neurol
; 91(2): 192-202, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967456
4.
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.
BMC Neurol
; 23(1): 207, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237267
5.
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 91(7): 681-686, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32371533
6.
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
J Peripher Nerv Syst
; 24(1): 48-55, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672091
7.
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. / Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose : Aktueller Stand und Empfehlungen in Deutschland.
Nervenarzt
; 90(12): 1245-1253, 2019 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-31297574
8.
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
Mult Scler
; 24(5): 632-641, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28436295
9.
Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.
Muscle Nerve
; 58(5): 681-687, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073683
10.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
Genet Epidemiol
; 39(8): 601-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497834
11.
PML risk stratification using anti-JCV antibody index and L-selectin.
Mult Scler
; 22(8): 1048-60, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26432858
12.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
BMC Neurol
; 16: 98, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405225
13.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
N Engl J Med
; 367(2): 115-23, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22784115
14.
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.
Mult Scler
; 20(13): 1714-20, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24842961
16.
Intravenous immunoglobulin maintenance treatment in myasthenia gravis: a randomized, controlled trial sample size simulation.
Muscle Nerve
; 50(6): 999-1004, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24710856
17.
Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple Sclerosis.
bioRxiv
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38370778
18.
Risk for myasthenia gravis maps to a (151) ProâAla change in TNIP1 and to human leukocyte antigen-B*08.
Ann Neurol
; 72(6): 927-35, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23055271
19.
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.
Mult Scler
; 19(11): 1454-61, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439578
20.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
J Peripher Nerv Syst
; 18(2): 130-40, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23781960